Literature DB >> 21454534

FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its beta1 subunit.

Stéphanie Bibert1, Chia-Chi Liu, Gemma A Figtree, Alvaro Garcia, Elisha J Hamilton, Francesca M Marassi, Kathleen J Sweadner, Flemming Cornelius, Käthi Geering, Helge H Rasmussen.   

Abstract

The seven members of the FXYD protein family associate with the Na(+)-K(+) pump and modulate its activity. We investigated whether conserved cysteines in FXYD proteins are susceptible to glutathionylation and whether such reactivity affects Na(+)-K(+) pump function in cardiac myocytes and Xenopus oocytes. Glutathionylation was detected by immunoblotting streptavidin precipitate from biotin-GSH loaded cells or by a GSH antibody. Incubation of myocytes with recombinant FXYD proteins resulted in competitive displacement of native FXYD1. Myocyte and Xenopus oocyte pump currents were measured with whole-cell and two-electrode voltage clamp techniques, respectively. Native FXYD1 in myocytes and FXYD1 expressed in oocytes were susceptible to glutathionylation. Mutagenesis identified the specific cysteine in the cytoplasmic terminal that was reactive. Its reactivity was dependent on flanking basic amino acids. We have reported that Na(+)-K(+) pump β(1) subunit glutathionylation induced by oxidative signals causes pump inhibition in a previous study. In the present study, we found that β(1) subunit glutathionylation and pump inhibition could be reversed by exposing myocytes to exogenous wild-type FXYD3. A cysteine-free FXYD3 derivative had no effect. Similar results were obtained with wild-type and mutant FXYD proteins expressed in oocytes. Glutathionylation of the β(1) subunit was increased in myocardium from FXYD1(-/-) mice. In conclusion, there is a dependence of Na(+)-K(+) pump regulation on reactivity of two specifically identified cysteines on separate components of the multimeric Na(+)-K(+) pump complex. By facilitating deglutathionylation of the β(1) subunit, FXYD proteins reverse oxidative inhibition of the Na(+)-K(+) pump and play a dynamic role in its regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454534      PMCID: PMC3099672          DOI: 10.1074/jbc.M110.184101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Identification of a phospholemman-like protein from shark rectal glands. Evidence for indirect regulation of Na,K-ATPase by protein kinase c via a novel member of the FXYDY family.

Authors:  Y A Mahmmoud; H Vorum; F Cornelius
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

2.  The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression.

Authors:  K J Sweadner; E Rael
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

Review 3.  Functional modulation of the sodium pump: the regulatory proteins "Fixit".

Authors:  Flemming Cornelius; Yasser A Mahmmoud
Journal:  News Physiol Sci       Date:  2003-06

4.  Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium.

Authors:  C F Presti; L R Jones; J P Lindemann
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  A role for the beta-subunit in the expression of functional Na+-K+-ATPase in Xenopus oocytes.

Authors:  K Geering; I Theulaz; F Verrey; M T Häuptle; B C Rossier
Journal:  Am J Physiol       Date:  1989-11

6.  Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties.

Authors:  Gilles Crambert; Maria Fuzesi; Haim Garty; Steven Karlish; Kathi Geering
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-08       Impact factor: 11.205

7.  Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.

Authors:  Michal Grzmil; Silke Voigt; Paul Thelen; Bernhard Hemmerlein; Katrin Helmke; Peter Burfeind
Journal:  Int J Oncol       Date:  2004-01       Impact factor: 5.650

8.  Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction.

Authors:  David W Starke; P Boon Chock; John J Mieyal
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

9.  Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells.

Authors:  Yao-Ting Huang; Shih-Chieh Chueh; Che-Ming Teng; Jih-Hwa Guh
Journal:  Biochem Pharmacol       Date:  2004-02-15       Impact factor: 5.858

10.  The fourth transmembrane segment of the Na,K-ATPase alpha subunit: a systematic mutagenesis study.

Authors:  Jean-Daniel Horisberger; Solange Kharoubi-Hess; Saïda Guennoun; Olivier Michielin
Journal:  J Biol Chem       Date:  2004-04-28       Impact factor: 5.157

View more
  38 in total

Review 1.  Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress.

Authors:  Jiang Liu; Megan N Lilly; Joseph I Shapiro
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

2.  Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction.

Authors:  Chia-Chi Liu; Keyvan Karimi Galougahi; Robert M Weisbrod; Thomas Hansen; Ramtin Ravaie; Andrea Nunez; Yi B Liu; Natasha Fry; Alvaro Garcia; Elisha J Hamilton; Kathleen J Sweadner; Richard A Cohen; Gemma A Figtree
Journal:  Free Radic Biol Med       Date:  2013-06-28       Impact factor: 7.376

Review 3.  S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing.

Authors:  Yang Yang; Xin Jin; Chun Jiang
Journal:  Antioxid Redox Signal       Date:  2013-08-20       Impact factor: 8.401

Review 4.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

Review 5.  How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

Review 6.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

7.  β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A Fry; Elisha J Hamilton; Gemma A Figtree; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

8.  FXYD2, a γ subunit of Na⁺, K⁺-ATPase, maintains persistent mechanical allodynia induced by inflammation.

Authors:  Feng Wang; Bing Cai; Kai-Cheng Li; Xu-Ye Hu; Ying-Jin Lu; Qiong Wang; Lan Bao; Xu Zhang
Journal:  Cell Res       Date:  2015-01-30       Impact factor: 25.617

9.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

10.  Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A S Fry; Elisha J Hamilton; Helge H Rasmussen; Gemma A Figtree
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.